Neoadjuvant target therapy with ensartinib in lung adenocarcinoma with EML4-ALK fusion variant: a case report and literature review
1. 系统已在2025-07-18 16:16:08对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1097/cad.0000000000001432
文献链接: https://journals.lww.com/10.1097/CAD.0000000000001432
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Yimin Wu; Lijian Huang; Wenshan Li; Ying Chai